These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28017218)

  • 41. Nerve Ultrasound Predicts Treatment Response in Chronic Inflammatory Demyelinating Polyradiculoneuropathy-a Prospective Follow-Up.
    Härtig F; Ross M; Dammeier NM; Fedtke N; Heiling B; Axer H; Décard BF; Auffenberg E; Koch M; Rattay TW; Krumbholz M; Bornemann A; Lerche H; Winter N; Grimm A
    Neurotherapeutics; 2018 Apr; 15(2):439-451. PubMed ID: 29435815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding the consequences of chronic inflammatory demyelinating polyradiculoneuropathy from impairments to activity and participation restrictions and reduced quality of life: the ICE study.
    Merkies IS; Hughes RA; Donofrio P; Bril V; Dalakas MC; Hanna K; Hartung HP; Latov N; van Doorn PA; Deng C;
    J Peripher Nerv Syst; 2010 Sep; 15(3):208-15. PubMed ID: 21040143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
    De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
    J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
    Lotan I; Hellman MA; Steiner I
    Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of clinically atypical with typical chronic inflammatory demyelinating polyradiculoneuropathy.
    Misra UK; Kalita J; Yadav RK
    Eur Neurol; 2007; 58(2):100-5. PubMed ID: 17565223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Office immunotherapy in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy.
    Dyck PJ; Taylor BV; Davies JL; Mauermann ML; Litchy WJ; Klein CJ; Dyck PJ
    Muscle Nerve; 2015 Oct; 52(4):488-97. PubMed ID: 25976871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparing the NIS vs. MRC and INCAT sensory scale through Rasch analyses.
    Draak TH; Vanhoutte EK; van Nes SI; Gorson KC; Van der Pol WL; Notermans NC; Nobile-Orazio E; Lewis RA; Léger JM; Van den Bergh PY; Lauria G; Bril V; Katzberg H; Lunn MP; Pouget J; van der Kooi AJ; Hahn AF; van den Berg LH; van Doorn PA; Cornblath DR; Faber CG; Merkies IS;
    J Peripher Nerv Syst; 2015 Sep; 20(3):277-88. PubMed ID: 26110493
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuromuscular disease-specific questionnaire to assess quality of life in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Kacar A; Bjelica B; Bozovic I; Peric S; Nikolic A; Cobeljic M; Petrovic M; Stojanov A; Djordjevic G; Vukojevic Z; Dominovic-Kovacevic A; Stojanovic M; Stevic Z; Rakocevic-Stojanovic V; Lavrnic D; Basta I
    J Peripher Nerv Syst; 2018 Mar; 23(1):11-16. PubMed ID: 29360221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrophysiological entrapment syndromes in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Muscle Nerve; 2011 Sep; 44(3):444-7. PubMed ID: 21996806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral nerve electrophysiology studies in relation to fatigue in patients with chronic inflammatory demyelinating polyneuropathy.
    Lawley A; Abbas A; Seri S; Rajabally YA
    Clin Neurophysiol; 2020 Dec; 131(12):2926-2931. PubMed ID: 32928696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): Clinical Features, Diagnosis, and Current Treatment Strategies.
    Reynolds J; Sachs G; Stavros K
    R I Med J (2013); 2016 Dec; 99(12):32-35. PubMed ID: 27902997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy.
    Grüter T; Motte J; Fisse AL; Bulut Y; Köse N; Athanasopoulos D; Otto S; Yoon MS; Schneider-Gold C; Gold R; Pitarokoili K
    Eur J Neurol; 2020 Dec; 27(12):2595-2603. PubMed ID: 32794258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice.
    Gorson KC; van Schaik IN; Merkies IS; Lewis RA; Barohn RJ; Koski CL; Cornblath DR; Hughes RA; Hahn AF; Baumgarten M; Goldstein J; Katz J; Graves M; Parry G; van Doorn PA
    J Peripher Nerv Syst; 2010 Dec; 15(4):326-33. PubMed ID: 21199104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early predictive factors of disability in CIDP.
    Spina E; Topa A; Iodice R; Tozza S; Ruggiero L; Dubbioso R; Esposito M; Bruzzese D; Santoro L; Manganelli F
    J Neurol; 2017 Sep; 264(9):1939-1944. PubMed ID: 28770373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
    Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
    Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early axonal loss predicts long-term disability in chronic inflammatory demyelinating polyneuropathy.
    Al-Zuhairy A; Jakobsen J; Krarup C
    Clin Neurophysiol; 2021 Apr; 132(4):1000-1007. PubMed ID: 33581994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort study.
    Liu B; Hu J; Sun C; Qiao K; Xi J; Zheng Y; Sun J; Luo S; Zhao Y; Lu J; Lin J; Zhao C
    J Neurol; 2023 Sep; 270(9):4288-4295. PubMed ID: 37195346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
    Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
    J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased muscle echointensity correlates with clinical disability and muscle strength in chronic inflammatory demyelinating polyneuropathy.
    Fisse AL; Fiegert S; Stoykova Z; Brünger J; Athanasopoulos D; Grüter T; Motte J; Gold R; Pitarokoili K
    Eur J Neurol; 2021 May; 28(5):1698-1705. PubMed ID: 33404183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.